PharmTech

What Sparsentan's FDA Approval Means for Rare Kidney Disease

Full FDA approval covers proteinuria reduction in FSGS without nephrotic syndrome, a defined clinical subset differentiated ...
Reuters

Exclusive: FDA leaders pushed to cut Lilly weight-loss pill review time

FDA chief's office said it wants to cut the filing review from 60 days to one week The office said it may cut those reviews to two or three weeks based on complexity The agency could decide on Lilly's ...

FDA Approval Process for Medical Devices Course: How to Make the Most of the FDA Pre-submission Process (June 30, 2026 and July 1, 2026)

The course offers key opportunities in understanding U.S. medical device approval pathways, including 510(k), IDE, PMA, and De Novo. It enhances practical skills through interactive case studies and ...

FDA approves Eli Lilly weight-loss pill Foundayo: What to know

FDA approved the Eli Lilly’s daily weight‑loss pill, a fast‑tracked GLP‑1 drug offering a new option for obesity treatment.